# FDA 483 - University of Vermont Health Network - April 24, 2026

Source: https://www.keypedia.com/records/483/university-of-vermont-health-network/9fe527d1-b38c-426a-a43f-41a1e860b5e1

> FDA 483 for University of Vermont Health Network on April 24, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: University of Vermont Health Network
- Inspection Date: 2026-04-24
- Product Type: biologics
- Office Name: New York District Office
- Summary: An FDA inspection of the University of Vermont Health Network - Adirondack Blood Center in Plattsburgh, NY, identified two significant observations. The facility failed to properly prepare venipuncture sites for whole blood collection, not adhering to their own procedures or manufacturer instructions. Additionally, the firm did not ensure adequate temperature monitoring for critical supplies, potentially compromising product integrity.

## Related Officers

- [FDA_PERSONNEL](https://www.keypedia.com/people/chanel-e-crawford/9bad6899-4c17-405f-babb-554cee8d09e7)

Company: https://www.keypedia.com/companies/university-of-vermont-health-network/849d85ea-b0e0-48ab-9a74-3369a87f5795

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d